UK Banks Report Surge in APP Fraud Losses as Pressure Mounts on Meta and Tech Platforms 
North Korea Reports Industrial Output at 105% of Target Following Party Congress 
BOJ Raises Interest Rates to 1% as Inflation Pressures Persist 
Woodside Energy Denies Exxon Mobil Takeover Talks Amid LNG Growth Focus 
BOJ Raises Interest Rates to 31-Year High, Signals Strong Focus on Inflation Risks 
Jio IPO Filing Nears as Reliance Targets $4 Billion Market Debut 
US-Iran Ceasefire Deal Extends Peace Talks and Eases Oil Trade Restrictions 
AI Memory Boom Sparks Global Chip Supply Crunch 
Asian Currencies Steady as BOJ Raises Rates and Markets Await Fed Decision 
Myanmar Economic Outlook Hit by Fuel Price Shock as World Bank Cuts Growth Forecast 
SpaceX Stock Gets $175 Target as Analysts See Massive Growth Ahead 
GM Explores Defense Manufacturing Partnership With Lockheed Martin 
Lazard Challenges Centerview for Role in Venezuela’s Massive Debt Restructuring 
SoftBank Vision Fund CFO Navneet Govil to Exit After Decade-Long Tenure 
Oil Prices Tumble as U.S.-Iran Peace Deal Eases Supply Concerns 
U.S.-Iran Peace Deal Extends Gulf Ceasefire, Reopens Strait of Hormuz 
Namyang Dairy saw a surge in its shares after claiming its Bulgaris yogurt variants can help lower the risk of COVID-19 infection. The company's day trading on Wednesday, April 14, reportedly increased.
As per The Korea Herald, Namyang Dairy’s shares once shot up by 28.68% to KRW489,000 or around $437.39 in the early morning trading. It was added that within 20 minutes after the opening bell, the company’s preferred stocks also surge by the daily allowable limit of 29.78% to reach KRW231,000.
Prior to Wednesday’s results, it was reported that the firm’s shares went up 7.19% and 6.71% on Friday and Monday, respectively. It then increased again by 8.57% on Tuesday, and this shows that Namyang Dairy’s shares have been on the rise since last weekend and continued this week.
Namyang’s COVID-19 claim
Observers are saying that the company’s surge in shares may be due to its claims that its Bulgaris yogurt lineup can help reduce the risk of getting COVID-19. Some market insiders also think that some investors may have also used information that caused the hike in the recent stock tradings.
At any rate, what triggered the sudden increase in shares of Namyang Dairy was the statement given by the company during a news conference in Seoul.
“We’re the first firm in the country that has discovered fermented dairy products are effective in preventing influenza and COVID-19 viruses,” Namyang’s chief of antiviral immune research center, Park Jong Su, said at that time. “Our experiments showed that Bulgaris helped remove the Influenza A (H1N1) virus at a 99.999 percent rate of success, and the COVID-19 at a 77.8 percent success rate.”
He added that the test of the yogurt’s effectiveness in fighting coronavirus was done using the lung cells of a monkey. As a result of this claim, people reportedly rushed out to purchase Namyang Dairy’s Bulgaris yogurts in stores.
Statement from S. Korea’s health officials
After the announcement from Namyang, the public health authorities released a statement. The agency expressed its concern over the claims.
“The latest research result has not proved to be effective in eliminating those viruses in the human body,” the Korea Disease Control and Prevention Agency stated. “Therefore, it is hard to say whether it can serve as an actual prevention or treatment measure for (the viruses).”
